Frontier Capital Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
AC
SCM
Frontier Capital Management's BLUE Position: Q1 2021 in Review
Frontier Capital Management sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 9,619 shares — an estimated $5.39M sold.
Frontier Capital Management first reported a position in BLUE in Q4 2014 and held it in 25 quarters. The position peaked at $43.8M in Q4 2014. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.
- Frontier Capital Management reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
- Frontier Capital Management sold 9,619 bluebird bio shares in Q1 2021, an estimated $5.39M.
- Frontier Capital Management first reported a position in bluebird bio in Q4 2014 and held it in 25 quarters.
- Frontier Capital Management's bluebird bio position peaked at $43.8M in Q4 2014.
- 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.
Based on Frontier Capital Management's 13F filing for Q1 2021, filed 13 May 2021.